ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 68 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $18,000 | +38.5% | 1,471 | +13.8% | 0.00% | – |
| Q1 2016 | $13,000 | -40.9% | 1,293 | +30.1% | 0.00% | – |
| Q4 2015 | $22,000 | +4.8% | 994 | -22.8% | 0.00% | – |
| Q3 2015 | $21,000 | +162.5% | 1,287 | +269.8% | 0.00% | – |
| Q2 2015 | $8,000 | +14.3% | 348 | +28.4% | 0.00% | – |
| Q1 2015 | $7,000 | +16.7% | 271 | +1.9% | 0.00% | – |
| Q4 2014 | $6,000 | 0.0% | 266 | -9.2% | 0.00% | – |
| Q3 2014 | $6,000 | -14.3% | 293 | -6.1% | 0.00% | – |
| Q2 2014 | $7,000 | – | 312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 825,647 | $19,238,000 | 3.04% |
| SECTORAL ASSET MANAGEMENT INC | 1,392,485 | $32,445,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,000 | $1,748,000 | 0.43% |
| Eventide Asset Management | 52,800 | $1,230,000 | 0.17% |
| Alyeska Investment Group, L.P. | 250,434 | $5,835,000 | 0.13% |
| Convergence Investment Partners, LLC | 28,715 | $669,000 | 0.09% |
| COLUMBUS CIRCLE INVESTORS | 253,348 | $5,903,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 66,800 | $1,557,000 | 0.04% |
| Visium Asset Management, LP | 75,001 | $1,748,000 | 0.03% |
| Hodges Capital Management Inc. | 15,000 | $349,000 | 0.02% |